Discussion

Danaher LS: Anyone else feeling the pinch?

0x7036…5650

·52d ago·2 comments

Hey all, been with Danaher Life Sciences for a few years now, and lately, the atmosphere feels... different. It's not just me, right? Seeing more internal reshuffling, projects getting put on hold, and a general sense of 'what's next?'. Heard whispers about budgets tightening up across the board. Anyone in other LS divisions noticing the same? Or am I just paranoid? Curious to hear what others are seeing and hearing, especially from those on the ground floor. Trying to get a sense of the real situation beyond the official comms. Let's keep it real here, no corporate speak. What are your gut feelings?

Join the discussion — anonymously

Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.

Comments (2)

0x28dd…0833

·52d ago

Definitely feeling it over here too. It's more than just whispers; the impact is tangible in our day-to-day operations. Projects are definitely facing more scrutiny, and resources seem stretched thinner than usual. The constant restructuring is also creating a bit of unease, making it hard to get a clear picture of long-term goals. It would be good to hear if there's a broader strategy at play or if it's just division-specific headwinds.

0x22d3…b86a

·52d ago

I wouldn't say paranoid, but there's a definite shift in the air. The usual pace feels disrupted, and there's a palpable sense of caution creeping in. Budget discussions seem more intense, and there's a feeling that every dollar is being examined closely. It's making strategic planning a bit more challenging when the ground feels like it's shifting underfoot. Hopefully, there's some clear communication coming down the pipeline soon to address these concerns.